Literature DB >> 8770463

Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer.

D L Page1, W D Dupont, R A Jensen.   

Abstract

Micropapillary patterns of apocrine change in human female breasts are common histological findings. They have been identified as cancer associated and implicated as an indicator of cancer risk in a predictive manner. This study has stratified papillary apocrine change (PAC) into categories of increasing complexity using a combination of cytological and histological pattern rules. Cases (2,876) were identified in a review of 10,357 benign breast biopsies. Of 5966 women, 1613 and PAC and were followed for a median of 20 years after biopsy for the development of invasive carcinoma of the breast. There was a slight association with cancer risk elevation, but most of this disappeared when women with concurrent, specifically identified patterns of atypical hyperplasia (AH) were excluded from the groups with PAC. The resultant relative risk was only 1.2 after women with AH were excluded. Only 1% of the reviewed biopsies demonstrated highly complex patterns of PAC, and 20% of these had coexistent lesions of AH. Women with highly complex patterns of PAC without AH did experience a relative risk of 2.4 (95% confidence interval = 0.77-7.04) but without statistical significance. More than one-half of all PAC patterns occurred without concurrent foci of lesions of proliferative disease that are associated with a slight elevation of breast cancer risk (at least 1.5 times); when present without proliferative disease, there was no suggestion of later breast cancer risk for PAC.

Entities:  

Mesh:

Year:  1996        PMID: 8770463

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  11 in total

1.  Multiplex genotype analysis of invasive carcinoma and accompanying proliferative lesions microdissected from breast tissue.

Authors:  X Cui; H Feiner; Z Lin; H Li
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

2.  [Flat epithelial atypia].

Authors:  W Böcker; D Hungermann; J Tio; S Weigel; T Decker
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

Review 3.  [Diagnostics of benign ductal epithelial cell proliferation of the breast in biopsy material].

Authors:  H-P Sinn; C Flechtenmacher; S Aulmann
Journal:  Pathologe       Date:  2014-02       Impact factor: 1.011

4.  Cutaneous apocrine cystomatosis in three slaughter-aged pigs.

Authors:  Carlos López-Figueroa; Mariano Domingo; Bernat Martí; Enric Vidal; Joaquim Segalés
Journal:  J Vet Diagn Invest       Date:  2019-12-09       Impact factor: 1.279

Review 5.  The enigmatic nature of apocrine breast lesions.

Authors:  P Zagorianakou; N Zagorianakou; D Stefanou; G Makrydimas; N J Agnantis
Journal:  Virchows Arch       Date:  2006-03-29       Impact factor: 4.064

6.  Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast.

Authors:  C Jones; S Damiani; D Wells; R Chaggar; S R Lakhani; V Eusebi
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

7.  Immunohistochemical localisation of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors.

Authors:  A G Selim; C A Wells
Journal:  J Clin Pathol       Date:  1999-11       Impact factor: 3.411

Review 8.  Evaluation and management of high risk and premalignant lesions of the breast.

Authors:  D L Page; R A Jensen
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

9.  Encapsulated apocrine papillary carcinoma of the breast--a tumour of uncertain malignant potential: report of five cases.

Authors:  Melanie Seal; Christine Wilson; Gregory J Naus; Stephen Chia; Terry C Bainbridge; Malcolm M Hayes
Journal:  Virchows Arch       Date:  2009-10-28       Impact factor: 4.064

Review 10.  Non-operative breast pathology: apocrine lesions.

Authors:  C A Wells; G A El-Ayat
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.